Microbiome Research is Pushing New Horizons: Seventure Partners

4e002020-9332-4255-9010-8e2633e7b22farticleimage.jpg

13 June 2017 --- Rapidly advancing understanding of the relationship between humans and their symbiotic microbes, and how their imbalance (dysbiosis) triggers or contributes to diseases will transform opportunities for novel nutritional, diagnostic and therapeutic products, says a new report by Seventure Partners, a French venture capital firm targeting life sciences companies.

Published today at the start of the Microbiome Discovery and Development Congress in Berlin, the report, entitled The Human Microbiome: A New Protagonist in Managing Human Health, focuses on the gut microbiome, and describes recent scientific advances and the reaction of the life sciences and healthcare industry to this emerging field.

The report discusses the need to embrace dysbiosis, the holistic nature of the gut microbiome’s effects on the body and focuses on the micro-ecology – new targets and tools needed to decipher the microbiome. The report also delves into the issues around paradigm shift and opportunities in the field, highlighting those companies and the forefront of microbiome research and development.

Industry has already embraced the potential of the microbiome – from the small start-up to large corporates. In the report, Dr. Dirk Gevers, Global Head, Janssen Human Microbiome Institute, Johnson & Johnson says that “inevitably, the patient journey of the future will combine elements of microbiome diagnostics and prescription drugs, with host-specific therapy and nutrition.”

“Investing in the microbiome was considered exotic when we started six years ago. With a market predicted to be worth over half a billion US dollars by 2022, investing in microbiome based companies is now rapidly becoming mainstream, with an exponential growth of innovative companies being founded to develop products based on new biological insights,” says Isabelle de Crémoux, CEO and Managing Partner at Seventure Partners.

A total of US$744m was privately invested in microbiome companies focused on oncology, metabolic disease, infectious disease, gastrointestinal (GI) disorders and Clostridium difficile between 2011 and 2016. While over a third was invested in developing treatments for GI disorders (including Crohn’s disease and ulcerative colitis), 6% of the total was invested in the emerging oncology/microbiome interface. Metabolic diseases received a 16% split, while infectious diseases took a fifth. Investment into Clostridium difficile stood at 22%. Geographically, over US$600m was invested in North America, with the remainder invested in Europe.

According to Seventure Partners, the report features research based on an extensive literature review, supplemented by a series of interviews with leading scientists, industry executives, entrepreneurs and investors. It includes perspectives on the impact of the microbiome on the prevention, diagnosis and treatment of chronic diseases, the interface between nutrition and the pharmaceutical industry, as well as the current and future challenges that will need to be overcome, including evolving regulatory requirements. 

The findings of the report were previewed during Seventure’s workshop during Bio-Europe Spring in Barcelona.

Speaking during a webinar on the growing interest in microbiome and digestive health, Lu Ann Williams, Director of Innovation at Innova Market Insights, notes that gut health is an important facet of the trend toward personalized nutrition, creating interesting opportunities for product development in a wide range of categories.

“Consumers have an idea that there are foods that are good or better for them, and this is really the start of a personalized nutrition phase for the food industry.”

Despite strict regulations on health claims on consumer products in regions such as the EU, Williams points out that “Globally, we have seen a +25 percent growth over 2012 to 2016 for Food and Beverage launches with a digestive health claim.”

Related Articles

Nutrition & Health News

Satiety: Mushrooms may trump meat in helping to feel fuller for longer

19 Oct 2017 --- If breakfast is the most important meal of the day, then a new Mushroom Council-funded study suggests mushrooms may be one of the most important ingredients. The study on satiety, published in the October issue of the journal Appetite, indicates that eating a mushroom-rich breakfast may result in less hunger and a greater feeling of fullness after a mushroom breakfast compared to a meat breakfast.

Nutrition & Health News

Health claims on snack bar packaging lead to better consumer sensory acceptance: study

19 Oct 2017 --- A study looking into the influence of package and health-related claims on perception and sensory acceptability of snack bars has found that when health claims were given to consumers, a better sensory acceptance was observed. Among other findings, package attributes, price and flavor were also highlighted on purchase intention of bars.

Nutrition & Health News

Brussels sprouts and green tea could convert breast cancer from lethal to treatable form

19 Oct 2017 --- Researchers at the University of Alabama at Birmingham (UAB) have found a dietary combination that transforms the most lethal of all breast cancers into a highly treatable breast cancer. Specifically, scientists involved in the Scientific Reports study say sulforaphane – from cruciferous vegetables such as broccoli sprouts – along with polyphenols from green tea may be the key.

Nutrition & Health News

European parents increasingly turning to charities for meals, survey reveals

19 Oct 2017 --- A new survey by commissioned by Kellogg, has revealed that families are struggling to afford a balanced and healthy diet, and are increasingly reliant on Breakfast Clubs, foodbanks and charities, especially during school holidays. 

 

Nutrition & Health News

Food for the heart (Part 2): Consumer trends and innovations

19 Oct 2017 --- Food for heart health is a key trend in nutrition NPD, with many companies exploring ways in which to protect consumers against cardiovascular issues. Today, in the second part of a special report, NutritionInsight examines which consumer trends are driving innovation in the world of heart health products and what these innovations are.

More Articles
URL : http://www.nutritioninsight.com:80/news/microbiome-research-is-pushing-new-horizons-seventure-partners.html